BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

ImmunoGen Pages on BioPortfolio:

Biotechnology News Immunogen Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - TLR8 Antibody Search
30 Aug 2007 ... Rabbit polyclonal TLR8 antibody was raised against a peptide corresponding to 16 amino acids near the middle of human TLR8. IMMUNOGEN . ...
http://www.bioportfolio.com/antibody/TLR8.html...

Biotechnology News immunogen. amgen. tap. payload. juniu. antibodi ...
24 Nov 2009 ... ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use ... ImmunoGen, Inc, a biotechnology company that develops targeted ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - ubiquitin C Antibody Search
The Immunogen: Ubiquitin C-terminal hydrolase 1 (UCHL1) has several other names, such as ubiquitin carboxyl esterase L1, ubiquitin thiolesterase, . ...
http://www.bioportfolio.com/antibody/ubiquitin_C.html...

Biotechnology News immunogen. amgen. tap. zibbcom. licens ...
24 Nov 2009 ... Matching: immunogen amgen tap licens maytansinoid, Find similar documents ... ImmunoGen, Inc, a biotechnology company that develops targeted ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Human CDX2 Antibody Search
Immunogen: A synthetic peptide corresponding to residues near the N-terminus ... Immunogen. Prokaryotic recombinant protein corresponding to the 180 amino ...
http://www.bioportfolio.com/antibody/Human_CDX2.html...



...

BioPortfolio - JAK2 Antibody Search
Janus Activating Kinase 2 (JAK2) is a 130 kDa tyrosine kinase ... Recombinant fragment of human JAK2 expressed in E. coli. IMMUNOGEN. SPECIES REACTIVITY . ...
http://www.bioportfolio.com/antibody/JAK2.html...

Biotechnology News amgen Search
24 Nov 2009 ... ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use ... ImmunoGen licenses Amgen right to use TAP technology to develop ...
http://www.bioportfolio.co.uk/amgen-news.htm...

BioPortfolio - CCNA2 - cyclin A2
Immunogen. cyclin A2 antibody was produced in rabbits immunized with a synthetic peptide corresponding to a region of human CCNA2. ...
http://www.bioportfolio.com/gene/890-CCNA2.html...

Results from other life science and pharmaceutical sites:

Targeted Therapies for Cancer: ImmunoGen, Inc.
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood
...
http://www.immunogen.com/...

Antigen - Wikipedia, the free encyclopedia
Similarly, an immunogen is seen as a specific type of antigen. ... Cells present their immunogenic-antigens to the immune system via a histocompatibility ...
http://en.wikipedia.org/wiki/Antigen...

Job Opportunities: ImmunoGen, Inc.
ImmunoGen offers a rich and exciting work environment that gives its employees the power to succeed, the flexibility to grow intellectually and the ...
http://www.immunogen.com/wt/page/jobs...

ImmunoGen, Inc. - Google Finance
Get the latest on ImmunoGen, Inc. including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=NASDAQ:IMGN...

Contact Us: ImmunoGen, Inc.
24 Mar 2008 ... ImmunoGen, Inc. 830 Winter Street Waltham, MA 02451-1477. Tel 781-895-0600 ... ImmunoGen, Inc. 333 Providence Highway Norwood, MA 02062 ...
http://www.immunogen.com/wt/page/contact...

Evaluation of HIV-1 immunogen, an immunologic modifier ...
Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized ...
http://www.ncbi.nlm.nih.gov/pubmed/11056590...

Product Pipeline: ImmunoGen, Inc.
16 Oct 2009 ... Wholly-owned by ImmunoGen sanofi-aventis. Biogen Idec Biotest ... *Centocor has opt-in rights **ImmunoGen has opt-in rights ...
http://www.immunogen.com/wt/page/pipeline...

News: Amgen to Apply ImmunoGen TAP Technology to Another Cancer ...
20 Nov 2009 ... Amgen licensed the exclusive right to use ImmunoGen's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer ...
http://www.genengnews.com/news/bnitem.aspx?name=69043975...

Corporate Officers: ImmunoGen, Inc.
22 Oct 2009 ... Daniel Junius joined ImmunoGen as Chief Financial Officer (CFO) and Senior Vice President, Finance in May 2005, was promoted to Executive ...
http://www.immunogen.com/wt/page/leadership...

The impact of a boosting immunogen on the differentiation of ...
In the present study we evaluated the effect of three different immunogens-- recombinant vaccinia, recombinant adenovirus, and plasmid DNA--on the generation
...
http://www.ncbi.nlm.nih.gov/pubmed/17881444...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.